FP
Publicaties op Oncologisch.com
Patient-reported outcomes with belantamab mafodotin, pomalidomide, and dexamethasone versus bortezomib, pomalidomide,...
Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, an...
Belantamab mafodotin plus pomalidomide-dexamethason bij myeloom: DREAMM-8 fase III